Fundamental Analysis of TEMPEST THERAPEUTICS INC(NASDAQ:TPST) stock

Fundamental Rating

We assign a fundamental rating of 1 out of 10 to TPST. TPST was compared to 588 industry peers in the Biotechnology industry. TPST may be in some trouble as it scores bad on both profitability and health. TPST has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year TPST has reported negative net income.

TPST had a negative operating cash flow in the past year.

TPST had negative earnings in each of the past 5 years.

TPST had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

TPST has a Return On Assets of -57.16%. This is comparable to the rest of the industry: TPST outperforms 44.20% of its industry peers.

The Return On Equity of TPST (-110.20%) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
ROA	-57.16%
ROE	-110.2%
ROIC	N/A

ROA(3y)-57.76%

ROA(5y)-63.32%

ROE(3y)-128.62%

ROE(5y)-114.41%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

TPST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for TPST has been increased compared to 1 year ago.

Compared to 5 years ago, TPST has more shares outstanding

Compared to 1 year ago, TPST has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -3.69, we must say that TPST is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of -3.69, TPST perfoms like the industry average, outperforming 41.13% of the companies in the same industry.

A Debt/Equity ratio of 0.23 indicates that TPST is not too dependend on debt financing.

TPST's Debt to Equity ratio of 0.23 is on the low side compared to the rest of the industry. TPST is outperformed by 68.60% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.23
Debt/FCF	N/A
Altman-Z	-3.69

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

A Current Ratio of 4.29 indicates that TPST has no problem at all paying its short term obligations.

The Current ratio of TPST (4.29) is comparable to the rest of the industry.

A Quick Ratio of 4.29 indicates that TPST has no problem at all paying its short term obligations.

TPST has a Quick ratio (4.29) which is in line with its industry peers.

		Industry Rank	Sector Rank
Current Ratio	4.29
Quick Ratio	4.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 40.18% over the past year.

EPS 1Y (TTM)40.18%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q39.68%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

TPST is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.04% yearly.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y26.16%

EPS Next 2Y9.5%

EPS Next 3Y-0.01%

EPS Next 5Y39.04%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

TPST reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year TPST is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y9.5%

EPS Next 3Y-0.01%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

TPST does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

TEMPEST THERAPEUTICS INC

NASDAQ:TPST (5/1/2024, 7:26:30 PM)

Premarket: 3.46 -0.16 (-4.42%)

3.62

+0.15 (+4.32%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap80.33M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-57.16%
ROE	-110.2%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	4.29
Quick Ratio	4.29
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)40.18%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y26.16%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

TEMPEST THERAPEUTICS INC (TPST)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens